Bharat Biotech terminates MoU with Brazilian partners after graft allegations

Bharat Biotech had signed an MoU with Precisa Medicamentos and Envixia Pharmaceuticals LL.C on November 20 for the purpose of introducing Covaxin in the territory of Brazil.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news